An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission

An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission

Abstract Recombinant protein approaches offer major promise for safe and effective vaccine prevention of SARS-CoV-2 infection. We developed a recombinant spike protein vaccine (called NARUVAX-C19) and characterized its ability when formulated with a nanoemulsion adjuvant to induce anti-spike antibod...

Full description

Bibliographic Details
Main Authors: Kairat Tabynov, Nurkeldi Turebekov, Meruert Babayeva, Gleb Fomin, Toktassyn Yerubayev, Tlektes Yespolov, Lei Li, Gourapura J. Renukaradhya, Nikolai Petrovsky, Kaissar Tabynov
Format: Article
Language:English
Published: Nature Portfolio 2022-02-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-022-00450-8

Internet

https://doi.org/10.1038/s41541-022-00450-8

Similar Items